Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients
- PMID: 20192890
- PMCID: PMC3440611
- DOI: 10.3109/02813430903345074
Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients
Abstract
Objective: To explore the negative predictive value (NPV), positive predictive value (PPV), sensitivity, and specificity of natriuretic peptides, cut-off levels, and the impact of gender and age in elderly patients with systolic heart failure (HF).
Design: Cross-sectional exploratory study.
Setting: One primary healthcare centre.
Patients: A total of 109 patients with symptoms of HF were referred for echocardiographic examination with a cardiovascular consultation. Systolic HF was diagnosed (ESC guidelines) in 48 patients (46% men, 54% women, mean age 79 years) while 61 patients (21% men, 79% women, mean age 76 years) had no HF.
Main outcome measures: NPV, PPV, sensitivity, specificity, and cut-off levels.
Results: Including all 109 patients, NPV was 88% for NT-proBNP (200 ng/L) and 87% for BNP (20 pg/ml). PPV was 81% for NT-proBNP (500 ng/L) and 68% for BNP (50 pg/ml). Sensitivity was 96% for NT-proBNP (100 ng/L) and 96% for BNP (10-20 pg/ml). Specificity was 87% for NT-proBNP (500 ng/L) and 71% for BNP (50 pg/ml). Nt-proBNP (beta = 0.035; p < 0.001) and BNP (beta = 0.030; p < 0.001) were associated with age, but not with gender. In a multivariate analysis age (beta = 0.036; p < 0.001) and male gender (beta = 0.270; p = 0.014) were associated with NT-proBNP, but only age for BNP (beta = 0.030; p < 0.001).
Conclusion: Natriuretic peptides in an elderly population showed high NPVs, but not as high as in younger patients with HF in other studies. Age and male gender were associated with higher levels of NT-proBNP while only age was related to elevated BNP levels.
Figures
Similar articles
-
Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.Scand Cardiovasc J. 2009;43(5):324-9. doi: 10.1080/14017430902769919. Scand Cardiovasc J. 2009. PMID: 19247872
-
The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.Br J Gen Pract. 2006 May;56(526):327-33. Br J Gen Pract. 2006. PMID: 16638247 Free PMC article.
-
Comparative value of BNP and NT-proBNP in diagnosis of heart failure.Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91. Rev Port Cardiol. 2004. PMID: 15478324 English, Portuguese.
-
Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017. Am J Cardiol. 2008. PMID: 18243855 Review.
-
The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.J Card Fail. 2007 Feb;13(1):50-5. doi: 10.1016/j.cardfail.2006.09.003. J Card Fail. 2007. PMID: 17339003 Review.
Cited by
-
Utility of NT-proBNP as a rule-out test for left ventricular dysfunction in very old people with limiting dyspnoea: the Newcastle 85+ Study.BMC Cardiovasc Disord. 2014 Sep 26;14:128. doi: 10.1186/1471-2261-14-128. BMC Cardiovasc Disord. 2014. PMID: 25257704 Free PMC article.
-
Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure.Front Cardiovasc Med. 2022 Feb 9;9:812654. doi: 10.3389/fcvm.2022.812654. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35224046 Free PMC article.
-
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.Heart Fail Rev. 2014 Aug;19(4):439-51. doi: 10.1007/s10741-014-9445-8. Heart Fail Rev. 2014. PMID: 24969534
-
Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study.BMJ Open. 2016 Oct 6;6(10):e012888. doi: 10.1136/bmjopen-2016-012888. BMJ Open. 2016. PMID: 27855108 Free PMC article.
References
-
- Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–18. - PubMed
-
- Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–40. - PubMed
-
- Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail. 2005;11:S15–20. - PubMed
-
- Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC., Jr Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous